Streetbeat News

Products Services

AQST

Aquestive Therapeutics Inc (NASDAQ:AQST) released topline pharmacokinetic data for its investigational product Anaphylm, an orally administered epinephrine prodrug for severe allergic reactions. The study showed no significant difference in drug absorption based on temperature and pH changes. The company plans to complete supportive studies and request a pre-NDA meeting with the FDA in Q3 2024.

Portfolio Pulse from Vandana Singh

June 25, 2024 | 5:00 pm

ALB

Albemarle Executive Eric Norris expressed confidence in the long-term demand for lithium and emphasized the need for more transparent lithium prices globally.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 4:55 pm

BLCO

CLSD

RGNX

Oppenheimer has initiated coverage on Clearside Biomedical Inc (NASDAQ:CLSD) with an Outperform rating and a price target of $5. The company is recognized for its pioneering suprachoroidal drug delivery system, which offers targeted and effective treatment for retinal diseases. Clearside's strategic partnerships with Bausch + Lomb Corp (NYSE:BLCO) and REGENXBIO Inc (NASDAQ:RGNX) further validate its technology. The stock is up 14.35% following the news.

Portfolio Pulse from Vandana Singh

June 25, 2024 | 4:54 pm

LLY

MRNA

MSFT

Eli Lilly (LLY) announced a collaboration with OpenAI, backed by Microsoft (MSFT), to leverage generative AI for inventing novel antimicrobials to treat drug-resistant pathogens. This partnership underscores Lilly's commitment to addressing antimicrobial resistance. Moderna (MRNA) also has an ongoing collaboration with OpenAI.

Portfolio Pulse from Vandana Singh

June 25, 2024 | 4:50 pm

MRIN

WMT

Marin Software discusses five strategies to enhance marketing reach using Walmart Connect. The article highlights the benefits of leveraging Walmart's advertising platform to improve brand visibility and drive sales.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 4:46 pm

IYE

XLE

XOM

ExxonMobil (XOM) has signed a non-binding MOU with SK On for a multiyear offtake agreement for up to 100,000 metric tons of Mobil Lithium from its Arkansas project. This aligns with ExxonMobil's goal to supply lithium for one million EV batteries annually by 2030. The project aims for efficient, environmentally friendly lithium production. Investors can gain exposure to XOM via Energy Select Sector SPDR Fund (XLE) and iShares U.S. Energy ETF (IYE).

Portfolio Pulse from Lekha Gupta

June 25, 2024 | 4:43 pm

IFBD

Infobird Co is considering expanding its operations into mainland China either organically or through a merger and acquisition with a target company.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 4:42 pm

SPY

Fed's Cook stated that it is challenging to push productivity beyond the long-term average and that it is too early to determine AI's impact on the economy and productivity.

Portfolio Pulse from Benzinga Newsdesk

June 25, 2024 | 4:39 pm

GM

General Motors (NYSE:GM) shares are trading lower due to a combination of factors including an increased price target from Wells Fargo, a fine from California regulators over a self-driving vehicle incident, and the withdrawal of GM Financial's deposit insurance application. Additionally, GM Defense announced a new project to provide battery-electric technology for military platforms.

Portfolio Pulse from Nabaparna Bhattacharya

June 25, 2024 | 4:35 pm

AMZN

GOOG

GOOGL

META

MSFT

MU

NVDA

ORCL

TSLA

Micron Technology Inc (NASDAQ:MU) presents an opportunity driven by artificial intelligence, but investors should be cautious. The company is experiencing high demand for its high bandwidth memory, which is essential for platforms like NVIDIA's and is being bought by major tech companies. However, memory is a commodity business with boom and bust cycles. Current pricing for memory products is high, benefiting Micron in the short term. Investors should consider the risks associated with earnings and market cycles.

Portfolio Pulse from The Arora Report

June 25, 2024 | 4:32 pm